Search hospitals > Illinois > Springfield
Southern Illinois University School of Medicine
Claim this profileSpringfield, Illinois 62702
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Recurrence
Conducts research for Leukemia
Conducts research for Lung Cancer
585 reported clinical trials
11 medical researchers
Summary
Southern Illinois University School of Medicine is a medical facility located in Springfield, Illinois. This center is recognized for care of Cancer, Tumors, Recurrence, Leukemia, Lung Cancer and other specialties. Southern Illinois University School of Medicine is involved with conducting 585 clinical trials across 774 conditions. There are 11 research doctors associated with this hospital, such as Bryan A. Faller, Gregory P. Brandt, James L. Wade, and Tom Ala.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Bryan A. FallerCrossroads Cancer Center1 year of reported clinical research
Expert in Cancer
Expert in Breast Cancer
220 reported clinical trials
287 drugs studied
Gregory P. BrandtSouthern Illinois University School of Medicine6 years of reported clinical research
Expert in Tumors
Expert in Lymphoma
40 reported clinical trials
85 drugs studied
James L. WadeDecatur Memorial Hospital3 years of reported clinical research
Studies Recurrence
Studies Breast Cancer
11 reported clinical trials
20 drugs studied
Tom AlaSouthern Illinois University School of Medicine2 years of reported clinical research
Studies Alzheimer's Disease
2 reported clinical trials
1 drug studied
Clinical Trials running at Southern Illinois University School of Medicine
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Acute Lymphoblastic Leukemia
Gastric Cancer
Renal Cell Carcinoma
Pancreatic Cancer
Esophageal Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Southern Illinois University School of Medicine?
Southern Illinois University School of Medicine is a medical facility located in Springfield, Illinois. This center is recognized for care of Cancer, Tumors, Recurrence, Leukemia, Lung Cancer and other specialties. Southern Illinois University School of Medicine is involved with conducting 585 clinical trials across 774 conditions. There are 11 research doctors associated with this hospital, such as Bryan A. Faller, Gregory P. Brandt, James L. Wade, and Tom Ala.
Where is Southern Illinois University School of Medicine located?
The Southern Illinois University School of Medicine hospital is located at 327 W Calhoun Ave, Springfield, IL 62702, near the intersection of N 1st St and W Calhoun Ave. It is approximately 1 mile north of downtown Springfield.
Who should I call to ask about financial aid or insurance network?
**Southern Illinois University School of Medicine Contact Information:**
- **Financial Assistance:** For inquiries, contact the SIU Medicine Billing and Insurance Department. Specific contact details are not provided online.
- **Insurance Matters:**
- Life Insurance: Securian Financial/Minnesota Life at 888/202-5525.
- Employee Assistance Program: Magellan Behavioral Health.
- **General Financial Inquiries:** Contact the Bursar's Office for tuition and fee payments at (618) 453-2221 (option one) or via SalukiNet for online payments.
- **Financial Aid:** Reach out to the Financial Aid Office at 217-545-2860 or financialaid@siumed.edu for assistance with financial aid packages, debt counseling, and short-term emergency loans.
What insurance does Southern Illinois University School of Medicine accept?
The Southern Illinois University School of Medicine mandates the SIUC Student Health Insurance Plan for students enrolled in on-campus courses. This comprehensive plan covers pharmaceuticals, immunizations, emergency room visits, hospitalizations, surgeries, ambulance services, and specialty care, complementing the services provided by the Student Health Center. Students with comparable health insurance coverage may opt out and receive a refund.
What awards or recognition has Southern Illinois University School of Medicine received?
Southern Illinois University School of Medicine in Springfield, Illinois, has been awarded $28.4 million in grants for research, training, and service in fiscal year 2023, marking a significant increase of over 20% from the previous year. The institution's research spans multiple disciplines such as invasive species control, wildlife disease surveillance, human health, advanced communications, and environmental concerns. Furthermore, the introduction of the Research Scholars Program acknowledges the research achievements of medical students.